(BPMC) Blueprint Medicines - Performance -1.7% in 12m
Compare BPMC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
4.05%
#35 in Group
Rel. Strength
41.00%
#4508 in Universe
Total Return 12m
-1.69%
#45 in Group
Total Return 5y
37.15%
#34 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -3.62%
59th Percentile in Group
12m Total Return: BPMC (-1.7%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: BPMC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BPMC
Total Return (including Dividends) | BPMC | XBI | S&P 500 |
---|---|---|---|
1 Month | 0.29% | -5.85% | -3.01% |
3 Months | 3.22% | -11.95% | -3.15% |
12 Months | -1.69% | -11.00% | 10.19% |
5 Years | 37.15% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | BPMC | XBI | S&P 500 |
1 Month | 14.6% | -59.8% | -5.5% |
3 Months | -44.5% | -70.5% | -58.4% |
12 Months | -25.3% | -6.9% | 84.1% |
5 Years | -3.50% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #50 | 6.52% | 3.40% |
3 Month | #31 | 17.2% | 6.58% |
12 Month | #44 | 10.5% | -10.8% |
5 Years | #37 | 36.3% | -40.2% |
FAQs
Does BPMC Blueprint Medicines outperforms the market?
Yes,
over the last 12 months BPMC made -1.69%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months BPMC made 3.22%, while XBI made -11.95%.
Over the last 3 months BPMC made 3.22%, while XBI made -11.95%.
Performance Comparison BPMC vs Indeces and Sectors
BPMC vs. Indices BPMC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.06% | 3.30% | -0.70% | -11.9% |
US NASDAQ 100 | QQQ | 0.92% | 4.35% | 0.07% | -10.3% |
US Dow Jones Industrial 30 | DIA | -0.26% | 2.43% | -1.62% | -11.2% |
German DAX 40 | DAX | 1.24% | 3.67% | -17.5% | -23.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.23% | 0.06% | 14.5% | -10.8% |
Hongkong Hang Seng | HSI | -2.03% | -2.48% | 8.52% | -19.0% |
India NIFTY 50 | INDA | -1.09% | -7.58% | 9.65% | -2.39% |
Brasil Bovespa | EWZ | -0.17% | -8.00% | 7.30% | 10.1% |
BPMC vs. Sectors BPMC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 1.48% | 4.10% | -8.81% | -20.9% |
Consumer Discretionary | XLY | -0.82% | 4.12% | -4.06% | -15.8% |
Consumer Staples | XLP | -2.85% | 2.13% | -1.54% | -12.7% |
Energy | XLE | -1.15% | -7.73% | -6.28% | -2.50% |
Financial | XLF | -0.54% | 2.99% | -12.9% | -23.9% |
Health Care | XLV | -0.48% | 3.45% | 4.0% | -3.38% |
Industrial | XLI | -0.37% | 0.98% | 0.01% | -10.2% |
Materials | XLB | -1.16% | -0.22% | 7.41% | 2.25% |
Real Estate | XLRE | -2.10% | 2.98% | 2.42% | -15.1% |
Technology | XLK | 1.07% | 4.30% | 4.42% | -3.70% |
Utilities | XLU | -3.35% | -0.53% | 0.18% | -26.9% |
Aerospace & Defense | XAR | 0.54% | -0.99% | -4.62% | -22.6% |
Biotech | XBI | 4.50% | 6.14% | 17.0% | 9.31% |
Homebuilder | XHB | -0.56% | 0.14% | 18.7% | 6.01% |
Retail | XRT | -2.36% | 0.79% | 3.38% | 3.10% |